Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system

Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system

US Patent 7989161 · Granted Aug 2, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polyvalent culture medium for anaerobic bacteria under aerobic conditions2021
Automated method for analyzing and interpreting an antimicrobial susceptibility2020
Use of uric acid for culturing bacteria sensitive to oxygen tension2020
Vulcanisaetal phosphotriesterase-like lactonases (PLL) having enhanced propertie2019
Method for the diagnosis of rosacea2018
Sulfolobal phosphotriesterase-like (PLL) lactonases activity having enhanced pro2018
Method for producing methane by means of aerobic co-culture of anaerobic micro-o2018
Use of squalamine or analogue as a disinfecting agent2017
Yeast-based assay for measuring the functional activity of an HIV-1 protease in 2016
Yeast-based assay for measuring the functional activity of an HIV-1 protease in 2016
Yeast-based assay for measuring the functional activity of an HIV-1 protease in 2016
Methods for improving and managing nucleoside reverse-transcriptase inhibition b2016